SUTRO BIOPHARMA, INC. (STRO) Stock Profile — Insider Trades & Financials

Revenue$11.6M

Net Income-$46.8M

EPS$-1.71

Market Cap$424.9M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Jane Chung

CEO & Executive Director

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.

Founded: 2003
Employees: 290
Headquarters: SOUTH SAN FRANCISCO, CA, United States
Website

⚡

Core Efficiency

ROE?

35.30%

ROA?

-26.90%

D/E Ratio?

-2.31

Op. Margin?

-326.69%

📊

Profitability Ratios

Net Margin?

-401.49%

Loading company sections...

SUTRO BIOPHARMA, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness